Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VRP 700

Drug Profile

VRP 700

Alternative Names: VRP-700

Latest Information Update: 28 Sep 2016

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Unknown
  • Developer Verona Pharma
  • Class Antitussives
  • Mechanism of Action Sensory receptor cell inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Cough

Highest Development Phases

  • No development reported Cough

Most Recent Events

  • 28 Sep 2016 VRP 700 is available for licensing as of 28 Sep 2016. http://www.veronapharma.com/joomla/index.php/products
  • 18 Feb 2016 No development reported - Phase-II for Cough in United Kingdom (Inhalation)
  • 25 Mar 2013 Phase-II clinical trials in Cough in United Kingdom (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top